Brief: Frequency Therapeutics Reports Publication Of Data Showing Hearing Improvements In Patients Receiving FX-322

Korro Bio

22/02/2021 21:01

Feb 22 (Reuters) - Frequency Therapeutics Inc  FREQ.O :
    * FREQUENCY THERAPEUTICS ANNOUNCES PUBLICATION OF PHASE 1/2
DATA
SHOWING HEARING IMPROVEMENTS IN ACQUIRED SENSORINEURAL HEARING
LOSS PATIENTS RECEIVING FX-322
    * FREQUENCY THERAPEUTICS INC - COMPANY EXPECTS INTERIM
FX-322
PHASE 2A STUDY DATA LATER THIS QUARTER
    * FREQUENCY THERAPEUTICS INC - STATISTICALLY SIGNIFICANT
IMPROVEMENTS OBSERVED IN WORD RECOGNITION TESTS IN QUIET AND IN
NOISE
    * FREQUENCY THERAPEUTICS INC - SUGGESTS POTENTIAL TO IMPROVE
SPEECH INTELLIGIBILITY, A MAJOR UNMET NEED FOR INDIVIDUALS WITH
HEARING LOSS
    * FREQUENCY THERAPEUTICS INC - RESULTS PUBLISHED IN LEADING
PEER-REVIEWED OTOLARYNGOLOGY JOURNAL, OTOLOGY & NEUROTOLOGY

Source text for Eikon:  ID:nBw1FvrKa 
Further company coverage:  FREQ.O 

 ((Reuters.Briefs@thomsonreuters.com;))